Very shoppers will soon be taking quizzes to help them find the products that are right for them on its website.
Answers to the quiz questions will help Very to personalise the products that customers are shown, following a new partnership with US tech platform Constructor. Very is to add Constructor’s AI-powered search, browse and autosuggest tools to its website and app. The tools learn from anonymous individual interactions and shopper behaviour to show customers the most relevant products at speed.
Paul Hornby, digital customer experience director at The Very Group, says: “Finding the right products quickly is a vital part of the overall digital customer experience, and we’re excited to be taking product discovery to the next level by partnering with Constructor.
“Ultimately, we want every customer to have an increasingly personalised experience of shopping with Very. The opportunities that AI and machine learning open up in this space are endless, and tapping into that via product discovery is a major step forward in our tech transformation journey.”
The move is the next step in Very Group’s tech investment roadmap which is set to give it flexible, cloud-based architecture supporting faster and more frequent customer experience improvements.
Eli Finkelshteyn, chief executive of Constructor, says:“It’s clear that Very is deeply dedicated to using technology to make their customer experience the best it can be. Constructor is honoured to be among those technologies, working to ensure the products that Very’s customers see are attractive and personalised to them and make their customer journey better.
“We’re looking forward to working with Very to make their strong and exciting vision for product discovery a reality and seeing the long-term results of our partnership.”
It has also partnered with commercetools to transform its ecommerce platform, True Fit for personalised size and fit guidance, Amplience for content creation and while it uses Modiface and Benefit for virtual make-up try-on functionality.
Very is ranked Top100 in RXUK Top500 research.
